Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 3Obesity 1Metabolic Syndrome 1Hyperandrogenism 1Cardiovascular Diseases 1

Interventions

Exercise 19Methods 8Diet Therapy 7Resistance Training 6Nutrition Assessment 6Early Intervention, Educational 5Diet 5Counseling 5Caloric Restriction 5Educational Status 4Diet, Mediterranean 4Standard of Care 3Metformin 3Yoga 2Therapeutics 2Surveys and Questionnaires 2Sugars 2Nutritional Status 2Mindfulness-Based Stress Reduction 2Diet, Carbohydrate-Restricted 2Dexamethasone 2Cognitive Behavioral Therapy 2Bariatric Surgery 2Adiposity 2Weights and Measures 1Weight Reduction Programs 1Walking 1Walk Test 1Vitamin D 1Trehalase 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Obesity × Spironolactone × Clear all
NCT01422759 2023-10-27

Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess

University of Virginia

Phase NA Unknown
20 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡